Loading...
Impact of safety monitoring on error probabilities of binary efficacy outcome analyses in large phase III group sequential trials
In phase III clinical trials, some adverse events may not be rare or unexpected and can be considered as a primary measure for safety, particularly in trials of life-threatening conditions, such as stroke or traumatic brain injury. In some clinical areas, efficacy endpoints may be highly correlated...
Na minha lista:
| Udgivet i: | Pharm Stat |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4294559/ https://ncbi.nlm.nih.gov/pubmed/22589042 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pst.1520 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|